Drug Shortage Report for M-LANSOPRAZOLE
Report ID | 165366 |
Drug Identification Number | 02489805 |
Brand name | M-LANSOPRAZOLE |
Common or Proper name | Lansoprazole |
Company Name | MANTRA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | LANSOPRAZOLE |
Strength(s) | 15MG |
Dosage form(s) | CAPSULE (DELAYED RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2022-07-01 |
Estimated end date | Unknown |
Actual end date | 2022-10-11 |
Shortage status | Resolved |
Updated date | 2022-11-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1000 RUE DU LUX SUITE 201 BROSSARD, QUEBEC CANADA J4Y 0E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2022-11-18 | French | Compare |
v3 | 2022-11-18 | English | Compare |
v2 | 2022-07-22 | French | Compare |
v1 | 2022-07-22 | English | Compare |
Showing 1 to 4 of 4